Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014909
Filing Date
2024-11-07
Accepted
2024-11-07 17:22:17
Documents
94
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20240930x10q.htm   iXBRL 10-Q 2113266
2 EX-31.1 irwd-20240930xex31d1.htm EX-31.1 16582
3 EX-31.2 irwd-20240930xex31d2.htm EX-31.2 16669
4 EX-32.1 irwd-20240930xex32d1.htm EX-32.1 7984
5 EX-32.2 irwd-20240930xex32d2.htm EX-32.2 8447
  Complete submission text file 0001558370-24-014909.txt   9516026

Data Files

Seq Description Document Type Size
6 EX-101.SCH irwd-20240930.xsd EX-101.SCH 79187
7 EX-101.CAL irwd-20240930_cal.xml EX-101.CAL 81159
8 EX-101.DEF irwd-20240930_def.xml EX-101.DEF 338436
9 EX-101.LAB irwd-20240930_lab.xml EX-101.LAB 582210
10 EX-101.PRE irwd-20240930_pre.xml EX-101.PRE 518631
97 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20240930x10q_htm.xml XML 1626307
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 241437175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)